SDSven-Erik Dahlén

Sven-Erik Dahlén

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sven-Erik Dahlén has a total of 373 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PGE2 Enhances Human ILC3 Function but Constrains ILC2‐to‐ILC3 Plasticity

    by Lorenz Wirth, Whitney Weigel, Efthymia Kokkinou, Johan Kolmert, Anna‐Karin Johnsson, Alessandro Quaranta, Craig Wheelock, Mattias Jangard, Ram V. Pandey, Sven‐Erik Dahlén, et al.

    Type 2 innate lymphoid cells (ILC2) drive eosinophilic asthma, whereas ILC3 and plastic ILC2/3 states are implicated in neutrophilic and mixed granulocytic disease endotypes. While lipid mediators regulate ILC2 function and airway inflammation, their role in human ILC3 biology and ILC plasticity remains poorly defined. We investigated how eicosanoid biosynthesis and signalling regulate human ILC2 and ILC3 function across canonical and plastic states. Here, we identified distinct prostaglandin (PG) profiles across ILC subsets. Unlike ILC2, which produce and rely on PGD 2 , ILC3 produced PGE 2 , which stimulated their release of IL‐17F and IL‐22. ILC2‐to‐ILC3 plasticity induced a biosynthetic switch towards PGE 2 production that correlated with IL‐17A and IL‐17F expression. However, subset‐intrinsic prostaglandin responses were preserved: hybrid ILC2/3 phenotypes, unlike bona fide ILC3, remained susceptible to PGE 2 ‐mediated inhibition, indicating a key functional distinction between these populations.Collectively, our data identify PGE 2 as a central regulator of ILC3 function, paralleling the role of PGD 2 in ILC2. These findings position PGs as key orchestrators of ILC subset function and plasticity and provide mechanistic insights into the regulation of ILC3 and hybrid ILC2/3 phenotypes associated with neutrophilic and mixed granulocytic asthma.

  • Open Access

    Topology-Based Query Framework for Longitudinal Omics Trajectories

    by Nazanin Zounemat-Kermani, Matthew Richardson, Alen Faiz, Siyao Wang, Kai Sun, Dragana Vuckovic, Maarten van Den Berge, Anke-Hilse Maitland-Van der Zee, Ian Sayers, Sven-Erik Dahlén, et al.

    1 1.1 Background: Many longitudinal omics studies contain only a small number of repeated measurements collected before, during, or after an intervention. Existing approaches, including mixed-effects models and generalized additive models, estimate temporal effects but do not generally provide a discrete representation of trajectory topology that can be queried directly across experimental groups. 1.2 Methods: We developed LongOmicsTraj, an open-source R package for topology-based representation and querying of short longitudinal omics trajectories. The framework encodes the direction of change between adjacent visits as up , down , or flat , with the ordered sequence defining an Ordinal Trajectory State (OTS). LongOmicsTraj operates downstream of trajectory estimation and can therefore be applied to empirical summaries or model-derived visit-level estimates, including those from linear mixed-effects models, generalized additive models, and polynomial regression, following a maSigPro-style time-course formulation [1]. OTS labels provide a common representation for topology-based querying, cross-group comparison, and evaluation of higher-level representations such as trajectory clusters. We evaluated the framework using controlled simulations and bronchial biopsy transcriptomic data from the GLUCOLD corticosteroid intervention study (GEO accession GSE36221 ), measured at baseline, 6 months, and 30 months. The biological analysis compared continued inhaled corticosteroid (ICS) treatment, ICS withdrawal after 6 months, and placebo. 1.3 Results: In simulations, LongOmicsTraj recovered predefined stable, monotonic, transient, rebound, and oscillatory trajectories with high accuracy when longitudinal signal was sufficiently clear, with performance declining under high-noise conditions and depending partly on the upstream estimator. In GLUCOLD, comparator-aware topology queries reduced 20,358 measured transcripts to 168 genes showing a corticosteroid response that was maintained during continued treatment, reversed following withdrawal, and was not reproduced under placebo. The selected genes included established corticosteroid-response genes and were enriched for immune-cell migration, chemotaxis, cell adhesion, and extracellular-matrix organisation. Topology-aware evaluation of FlexMix trajectory clusters additionally revealed substantial within-cluster temporal heterogeneity, with topology purities of approximately 46–60%. 1.4 Conclusions: LongOmicsTraj provides a compact, directly queryable representation of temporal direction and order in short longitudinal omics studies. It complements existing longitudinal estimation and clustering methods by making trajectory structure explicit, enabling structured cross-group queries and quantification of temporal heterogeneity within trajectory clusters.

  • Open Access

    The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients – a preliminary analysis

    by S.M. Vassileva, S. Shahbazi Khamas, N. Dyhre-Petersen, S. Principe, S.J. Vijverberg, B. Hilvering, E.J.M. Weersink, A. Lillieroth Bricaud, E.J. Bari, A. Sverrild, et al.

  • Open Access

    Associations between respiratory health, reported traffic, and occupational-related exposure

    by Johannes Saers, Josefin Sundh, Lena Andersson, Linda Ekerljung, Lars Modig, Sven-Erik Dahlen, Marit Westman, Christer Janson

    Rapid urbanisation over the past century has led to increased traffic density and higher levels of ambient air pollutants. We aimed to investigate whether the prevalence of respiratory symptoms, asthma, and chronic bronchitis increases with the level of self-reported exposure to traffic and occupational-related pollution. The study population comprised 25,889 general population subjects ages 16–75 years participating in the Swedish part of the GA2LEN study. Data were collected in the cities of Umeå, Uppsala, Stockholm, and Gothenburg. Self-reported data on disturbance of fumes from traffic in the residential area or occupational exposure to gas, dust, or smoke, as well as on patient demographics, respiratory symptoms, asthma and chronic bronchitis, were obtained from questionnaires. The prevalence of respiratory symptoms, asthma, and chronic bronchitis was higher both among participants reporting traffic-related exposure and those with a history of occupational exposure to fumes, smoke, and dust than among those unexposed; (wheeze 27 vs 13%), nocturnal cough (35 vs 22%), asthma (11 vs 6%) and chronic bronchitis (22 vs 8%); all p < 0.0001. When combining traffic and occupational exposure, the highest prevalence was found amongst those exposed to both. Associations with occupational exposure were generally stronger in women, and those with traffic exposure were stronger in men. In this large population-based sample, self-reported residential traffic exposure and occupational exposure to dust, fumes, or smoke were associated with increased prevalence of respiratory symptoms, asthma, and chronic bronchitis. Although causality cannot be inferred, these findings underscore the importance of assessing environmental and occupational exposures in evaluating respiratory health.


  • Open Access

    Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity

    by Lars I. Andersson, Maciej Kupczyk, Barbro Dahlén, Kenji Izuhara, Mina Gaga, Nikos M. Siafakas, Alberto Papi, Bianca Beghe, Guy Joos, Klaus F. Rabe, et al.

    Background: Obesity‐related asthma (OBA) is a distinct asthma phenotype, with increased severity. Adipokine release from excessive adipose tissue is suggested to be a key feature of OBA pathophysiology. However, it is unclear how the clinical characteristics of severe asthma associate with adipokine mediators. We examined systemic adipokine levels and evaluated relationships with disease severity, weight, sex, and steroid treatment in asthma. Methods: A multiplex immunoassay for nine adipokines with proposed involvement in obesity‐related inflammation (adiponectin, adipsin, BAFF, chemerin, FGF‐21, leptin, lipocalin‐2/NGAL, osteonectin and resistin) was designed. Plasma adipokines were measured in 127 patients with mild‐to‐moderate asthma (MMA) or severe asthma (SA) from the European BIOAIR cohort at baseline and after a controlled 2‐week oral corticosteroid (OCS) intervention. Results: Leptin and chemerin were significantly increased in patients with SA vs. MMA. Leptin, adiponectin, adipsin, and NGAL were affected by sex, whereas leptin and adipsin were strongly affected by weight. OCS increased leptin and adiponectin, decreased adipsin and BAFF, and did not affect osteonectin, resistin, or chemerin. No adipokines showed positive associations with exhaled NO, blood or sputum eosinophils, although certain correlations with serum CRP, blood, and sputum neutrophils were observed. Conclusions: Overall, we observe variable relationships between the nine adipokines, obesity and asthma severity. There were no relationships between adipokine levels and type‐2 airway inflammation, yet associations with systemic neutrophilic inflammation were seen. Although one adipokine, chemerin, was independently associated with asthma severity, deciphering the role of adipokines in OBA is complex due to the influence of sex, BMI, and OCS.


  • Open Access

    Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U‐BIOPRED Cohort

    by Joana Antão, Guilherme Rodrigues, Nazanin Zounemat-Kermani, Paolo Montuschi, Qichen Deng, Frits M E Franssen, Lars I Andersson, Ian M Adcock, Sven-Erik Dahlén, Scott S Wagers, et al.

    Background: Controlling asthma symptoms remains challenging. Understanding its molecular mechanisms may provide new insights into asthma pathophysiology. We explored the associations between the transcriptome and proteome in blood and sputum and asthma symptom control. Methods: This cross‐sectional study included asthmatic and healthy adults from the U‐ BIOPRED cohort. Uncontrolled symptoms were defined as a mean ≥ 1.5 points on the 5‐item asthma control questionnaire. Stability selection using LASSO logistic regression identified genes/proteins associated with symptom control, followed by logistic regression. Analyses were adjusted for age, sex, age of asthma onset, smoking status, body mass index ( BMI ), FEV 1 % predicted, exacerbation history, anti‐ IgE therapy and urinary steroid levels. The selected variables were compared with healthy controls using linear regression, adjusted for age, sex, BMI , smoking status and urinary steroid levels. Results: Four serum proteins were selected based on data from 415 asthmatics (median age 52 [41, 61] years; 59% female; 64% uncontrolled). Higher TWEAKR / TNFRSF12A [ OR 2.25 (95% CI 1.15, 4.77)] and MBL / MBP ‐C [1.6 (1.07, 2.42)] levels increased the odds of uncontrolled symptoms, whereas higher MK08 / MAPK8 [0.48 (0.29, 0.76)] and CD5L [0.59 (0.41, 0.82)] levels decreased the odds. CD5L levels were significantly lower in severe asthma than in healthy controls [estimate −0.23 (95% CI −0.41, −0.04)]. No associations were found between symptom control and the sputum proteome ( N = 90) or the sputum ( N = 96) and blood ( N = 360) transcriptomes. Conclusion: Four serum proteins distinguished asthmatics with uncontrolled from controlled symptoms. CD5L levels were also lower in asthmatics with severe disease than in healthy controls, warranting further investigation into its potential therapeutic value.


  • Open Access

    Formylpeptide receptors in GtoPdb v.2025.3

    by Magnus Bäck, Richard D. Ye, Ji Ming Wang, Takao Shimizu, Charles N. Serhan, G. Enrico Rovati, Mark Quinn, Helena Chengxue Qin, Marc Parmentier, Philip M. Murphy, et al.

    The human formylpeptide receptor subfamily of GPCRs (FPR: nomenclature described in [169, 227] [1, 2]) comprises three members (FPR1, FPR2, and FPR3). Two of these, FPR1 and FPR2, recognize peptides bearing N-terminal formyl-Met from invading bacteria [104] or mitochondria. These peptides function as danger signals in innate immunity. FPR1 and FPR2 are promiscuous and also recognize several non-formylated peptides, proteins, lipids and small molecules [169, 227, 104] of which some are able to initiate signals (balanced or biased) that mediate pro-inflammatory and/or inflammation resolving effects [136, 161]. In contrast, FPR3 remains less well-characterized in part due to the absence of selective ligands which has significantly impeded progress in its functional characterization [46, 173].

  • Open Access

    Leukotriene receptors in GtoPdb v.2025.3

    by Magnus Bäck, Mohib Uddin, Takao Shimizu, Charles N. Serhan, G. Enrico Rovati, Joshua Rokach, William Powell, Motonao Nakamura, Douglas W. P. Hay, Jilly F. Evans, et al.

    The leukotriene receptors (nomenclature as agreed by the NC-IUPHAR subcommittee on Leukotriene Receptors [36, 39]) are activated by the endogenous ligands leukotrienes (LT), synthesized from lipoxygenase metabolism of arachidonic acid. The human BLT1 receptor is the high affinity LTB4 receptor whereas the BLT2 receptor in addition to being a low-affinity LTB4 receptor also binds several other lipoxygenase-products, such as 12S-HETE, 12S-HPETE, 15S-HETE, and the thromboxane synthase product 12-hydroxyheptadecatrienoic acid. The BLT receptors mediate chemotaxis and immunomodulation in several leukocyte populations and are in addition expressed on non-myeloid cells, such as vascular smooth muscle and endothelial cells. In addition to BLT receptors, LTB4 has been reported to bind to the peroxisome proliferator activated receptor (PPAR) α [206] and the vanilloid TRPV1 ligand-gated nonselective cation channel [228]. The crystal structure of the BLT1 receptor was initially determined in complex with selective antagonists [145, 236] and extended to the cryo-electron microscopy structure of LTB4-bound human BLT1 receptor at 2.91 Å resolution [402]. The receptors for the cysteinyl-leukotrienes (i.e. LTC4, LTD4 and LTE4) are termed CysLT1 and CysLT2 and exhibit distinct expression patterns in human tissues, mediating for example smooth muscle cell contraction, regulation of vascular permeability, and leukocyte activation. The crystal structures of both receptors have been solved; CysLT1 in complex with zafirlukast and pranlukast [208] and CysLT2 in complex with three dual CysLT1/CysLT2 antagonists [126]. There is also evidence in the literature for additional CysLT receptor subtypes, derived from functional in vitro studies, radioligand binding and in mice lacking both CysLT1 and CysLT2 receptors [39]. Cysteinyl-leukotrienes have also been suggested to signal through the P2Y12 receptor [101, 256, 286], GPR17 [60] and the oxoglutarate receptor OXGR1 (previously referred to as GPR99) [177].

  • Open Access

    Formylpeptide receptors in GtoPdb v.2025.1

    by Magnus Bäck, Richard D. Ye, Ji Ming Wang, Takao Shimizu, Charles N. Serhan, G. Enrico Rovati, Mark Quinn, Marc Parmentier, Philip M. Murphy, Craig Gerard, et al.

    The formylpeptide receptors (nomenclature agreed by the NC-IUPHAR Subcommittee on the formylpeptide receptor family [150]) respond to exogenous ligands such as the bacterial product fMet-Leu-Phe (fMLF) and endogenous ligands such as lipoxin A4 (LXA4), 15-epi-lipoxin A4, annexin I , cathepsin G, amyloid β42, serum amyloid A and spinorphin, derived from β-haemoglobin. FPR1 also serves as a plague receptor for selective destruction of human immune cells by Y. pestis [135]. The FPR1/2 agonists 'compound 17b' and 'compound 43' have shown cardiac protective functions [149, 64].